Drug Repositioning for Alzheimer’s Disease Based on Systematic ‘omics’ Data Mining

Traditional drug development for Alzheimer’s disease (AD) is costly, time consuming and burdened by a very low success rate. An alternative strategy is drug repositioning, redirecting existing drugs for another disease. The large amount of biological data accumulated to date warrants a comprehensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ming, Schmitt-Ulms, Gerold, Sato, Christine, Xi, Zhengrui, Zhang, Yalun, Zhou, Ye, St George-Hyslop, Peter, Rogaeva, Ekaterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179106/
https://www.ncbi.nlm.nih.gov/pubmed/28005991
http://dx.doi.org/10.1371/journal.pone.0168812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179106/
https://www.ncbi.nlm.nih.gov/pubmed/28005991
http://dx.doi.org/10.1371/journal.pone.0168812

Ejemplares similares